Acadia: Q1 Earnings Snapshot

Published: 2022-05-04 17:12:20 ET ACAD

SAN DIEGO (AP) _ Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported a loss of $113.1 million in its first quarter.

The San Diego-based company said it had a loss of 70 cents per share.

The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The drugmaker posted revenue of $115.5 million in the period, which also missed Street forecasts. Eight analysts surveyed by Zacks expected $123.7 million.

Acadia shares have declined 15% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $19.89, a rise of roughly 2% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACAD at https://www.zacks.com/ap/ACAD